BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21719422)

  • 1. Age, gender and disease-related platelet and neutrophil activation ex vivo in whole blood samples from patients with Behçet's disease.
    Macey M; Hagi-Pavli E; Stewart J; Wallace GR; Stanford M; Shirlaw P; Fortune F
    Rheumatology (Oxford); 2011 Oct; 50(10):1849-59. PubMed ID: 21719422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
    Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
    Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?
    Martínez M; Ricart JM; Ruiz-Aja S; Rus A; Todolí J; Calvo J; Vayá A
    Pathophysiol Haemost Thromb; 2007; 36(1):18-22. PubMed ID: 18332610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil CD64 expression in Behçet's disease.
    Ureten K; Ertenli I; Oztürk MA; Kiraz S; Onat AM; Tuncer M; Okur H; Akdogan A; Apras S; Calgüneri M
    J Rheumatol; 2005 May; 32(5):849-52. PubMed ID: 15868620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived microparticles during and after acute coronary syndrome.
    Skeppholm M; Mobarrez F; Malmqvist K; Wallén H
    Thromb Haemost; 2012 Jun; 107(6):1122-9. PubMed ID: 22371053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative platelet and monocyte activation in patients with critical limb ischemia.
    Burdess A; Nimmo AF; Campbell N; Harding SA; Garden OJ; Dawson AR; Newby DE
    J Vasc Surg; 2010 Sep; 52(3):697-703. PubMed ID: 20816321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
    Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
    Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study.
    Pamuk GE; Pamuk ON; Orüm H; Demir M; Turgut B; Cakir N
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):113-7. PubMed ID: 20135752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of soluble E-selectin in patients with active Behcet's disease.
    Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
    Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced microparticles in ventricular assist device patients predict platelet, leukocyte and endothelial cell activation.
    Diehl P; Aleker M; Helbing T; Sossong V; Beyersdorf F; Olschewski M; Bode C; Moser M
    Interact Cardiovasc Thorac Surg; 2010 Aug; 11(2):133-7. PubMed ID: 20472650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of glycoprotein IIb/IIIa inhibitors on CD62p expression, platelet aggregates, and microparticles in vitro.
    Matzdorff AC; Kühnel G; Kemkes-Matthes B; Pralle H; Voss R; Fareed J
    J Lab Clin Med; 2000 Mar; 135(3):247-55. PubMed ID: 10711863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis.
    Jurk K; Ritter MA; Schriek C; Van Aken H; Droste DW; Ringelstein EB; Kehrel BE
    Thromb Haemost; 2010 Jun; 103(6):1193-202. PubMed ID: 20352160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactive leptin resistance and the profile of platelet activation in acute ischaemic stroke patients.
    Lukasik M; Michalak S; Dworacki G; Siewiera K; Kaczmarek M; Watala C; Kozubski W
    Thromb Haemost; 2012 Jul; 108(1):107-18. PubMed ID: 22627503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet soluble CD40L and matrix metalloproteinase 9 activity are proinflammatory mediators in Behçet disease patients.
    Fernández Bello I; Álvarez MT; López-Longo FJ; Arias-Salgado EG; Martín M; Jiménez-Yuste V; Rodríguez de la Rúa A; Butta NV
    Thromb Haemost; 2012 Jan; 107(1):88-98. PubMed ID: 22116092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does renal carcinoma affect the expression of P-selectin on platelets?
    Mantur M; Kemona H; Pietruczuk M; Wasiluk A
    Neoplasma; 2002; 49(4):243-5. PubMed ID: 12382022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.